The objectives ofthe Columbia University Education and Information Core are: to provide training to physicians about Alzheimer's disease;to facilitate the recruitment and retention of research participants;to develop innovative and culturally sensitive outreach programs to educate the community and promote ADRC activities;and to complement and support the initiatives of the Clinical Core, the Neuropathology Core and the Genetics Core. To meet these objectives, we will build upon our past successes to expand our reach and impact. Over the next 5 years, the Education Core will continue our comprehensive education program for physicians-in-training with lectures and outpatient electives. We will continue to design and implement seminars, presentations, publications, and CME courses to familiarize clinicians with standard of care and research trends in the diagnosis, treatment, and management of dementia. The Education Core will continue our service-specific activities of providing education to caregivers and the lay public about disease treatment and research opportunities. We will continue to design educational programs for the community using culturally sensitive information, presentations and materials, with a specific focus on addressing participation in clinical trials and obtaining permission for brain autopsy. Using our highly successful African American outreach program as a model, we will expand outreach to the Hispanic community to include community presentations and outreach to Latino physicians. We will meet our service-specific aim of facilitating recruitment into the genetics initiative by designing educational programs targeted to minorities. New programs will be designed to assist the Clinical Core in obtaining permission for lumbar puncture for CSF biomarkers. We will expand our services to include an early stage caregiver support group and educational workshop series. We will continue and develop the evaluation of our programs to ensure that they meet the educational objectives and goals.

Public Health Relevance

Alzheimers disease affects more than 5 million people but still remains underdiagnosed and undertreated. Education of the lay public and physicians is necessary to increase awareness about the disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG008702-25
Application #
8664313
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
25
Fiscal Year
2014
Total Cost
$110,673
Indirect Cost
$41,511
Name
Columbia University
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Winawer, Melodie R; Griffin, Nicole G; Samanamud, Jorge et al. (2018) Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Ann Neurol 83:1133-1146
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Qureshi, Yasir H; Patel, Vivek M; Berman, Diego E et al. (2018) An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect. Mol Cell Biol 38:
Reitz, Christiane (2018) Retromer Dysfunction and Neurodegenerative Disease. Curr Genomics 19:279-288
Tariciotti, Leonardo; Casadei, Matthew; Honig, Lawrence S et al. (2018) Clinical Experience with Cerebrospinal Fluid A?42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia. J Alzheimers Dis 65:1417-1425
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Masucci, Michael D; Lister, Amanda; Corcoran, Cheryl M et al. (2018) Motor Dysfunction as a Risk Factor for Conversion to Psychosis Independent of Medication Use in a Psychosis-Risk Cohort. J Nerv Ment Dis 206:356-361

Showing the most recent 10 out of 640 publications